Details for Patent: 11,911,370
✉ Email this page to a colleague
Which drugs does patent 11,911,370 protect, and when does it expire?
Patent 11,911,370 protects QINLOCK and is included in one NDA.
This patent has thirty-three patent family members in eighteen countries.
Drugs Protected by US Patent 11,911,370
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Deciphera Pharms | QINLOCK | ripretinib | TABLET;ORAL | 213973-001 | May 15, 2020 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 11,911,370
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Argentina | 122354 | ⤷ Sign Up | |||
Argentina | 122355 | ⤷ Sign Up | |||
Australia | 2020417282 | ⤷ Sign Up | |||
Australia | 2020419197 | ⤷ Sign Up | |||
Australia | 2023241368 | ⤷ Sign Up | |||
Australia | 2023248048 | ⤷ Sign Up | |||
Brazil | 112022013109 | ⤷ Sign Up | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |